- Avricore Health Inc is a pharmacy solutions provider that combines best-in-class point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues
- The wholly owned subsidiary, HealthTab™, offers fast, accurate and cost-effective point-of-care screening. With just a few drops of blood from a finger prick, results are available on the spot and data is available in real time.
- The current test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g. HbA1c, Lipid Profile, eGFR). HealthTab™ also recently added capabilities for bacterial and viral tests, such as strep and COVID-19
- The company leverages strategic partnerships with notable names in the diagnostic space, including Abbott Rapid Diagnostics, a global healthcare company and leader in diagnostics. This partnership allows Avricore to use Abbott’s Afinion 2™ analyzer to offer high-quality, low-cost screening tests
- In June 2021, Avricore announced its master agreement to pilot its HealthTab™ platform for diabetes management in select Shoppers Drug Mart pharmacies
- Avricore’s ultimate aim is to make actionable health information more accessible to everyone by creating the world’s largest network of rapid testing devices in community pharmacy
- The company expanded patient testing with the HealthTab™ platform in select Shoppers Drug Mart® pharmacies in British Columbia, bringing its diabetes screening program to Western Canada for the first time.
The point-of-care testing (POCT) market is expected to reach US$103.2 billion by 2030 from US$40.6 billion in the year 2021 at a CAGR of 10.92 percent from 2022 to 2030.
The accessibility of POCT has been an increasing priority of the world’s leading health organizations and experts. Pharmacies are ideal ‘hubs’ within the community to offer patients better access to the numbers they need to know for preventing or treating conditions such as diabetes and heart disease or the timely diagnosis of infection.
Avricore Health Inc. (TSXV:AVCR, OTCQB: AVCRF) is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward. Through its flagship offering HealthTab™ (a wholly owned subsidiary), its mission is to make actionable health information more accessible to everyone by creating the world’s largest network of rapid testing devices in community pharmacies.